WCPO: Cincinnati a hub for stroke research
March 18, 2024
WCPO highlighted the Steps for Stroke 2024 event, raising money to advance stroke research at the University of Cincinnati.
March 18, 2024
WCPO highlighted the Steps for Stroke 2024 event, raising money to advance stroke research at the University of Cincinnati.
March 18, 2024
An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
March 13, 2024
The University of Cincinnati's Kelly Dobos spoke with The Cut about the risk of benzene exposure in common acne products.
March 6, 2024
The University of Cincinnati's Trisha Wise-Draper, MD, PhD, spoke with WDTN Dayton to discuss the approval of Amtagvi, the first cellular therapy for metastatic or unresectable melanoma, a harmful skin cancer.
March 6, 2024
University of Cincinnati Cancer Center researchers in the lab of Jun-Lin Guan, PhD, have identified a new protein that helps prevent metastasis of a subset called HER2-positive breast cancer.
March 4, 2024
The University of Cincinnati's Oluwole Awosika commented to Medscape on a new study that found a vibrating glove device could help manage hand spasticity symptoms after a stroke.
March 4, 2024
A clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found the drug liraglutide was safe and effective for weight loss for patients with stable bipolar disorder.
February 29, 2024
Regional media highlighted the University of Cincinnati Cancer Center being the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.
February 29, 2024
A University of Cincinnati Cancer Center study published in the journal JAMA Network Open found real-time navigation is a useful tool for surgeons performing ablation procedures to destroy tumors in the liver.
February 26, 2024
The University of Cincinnati's Susan McElroy, MD, spoke with CNN about the impact weight loss medications like semaglutide have on people with eating disorders.